NO | ထုတ်ကုန်များ | CAS နံပါတ် | အဓိက အရည်အသွေး အညွှန်း | |||
သန့်ရှင်းစင်ကြယ်ခြင်း။ | မက်။ စိတ်ညစ်ညူးခြင်း။ | စုစုပေါင်းပျော်ရည်အကြွင်းအကျန် | အစိုဓာတ် | |||
1 | Fmoc-β-Ala-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
2 | Fmoc-D-Ala-D-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
3 | Fmoc-β-Ala-D-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
4 | Fmoc-Arg(pbf)-Arg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
5 | Fmoc-β-Ala-Arg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
6 | Fmoc-D-Arg(pbf)-D-Arg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
7 | Fmoc-β-Ala-D-Arg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
8 | Fmoc-HomoArg(pbf)-HomoArg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
9 | Fmoc-β-Ala-HomoArg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
10 | Fmoc-Asn(Trt)-Asn(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
11 | Fmoc-β-Ala-Asn(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
12 | Fmoc-Asp(OtBu)-Asp(OtBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
13 | Fmoc-β-Ala-Asp(OtBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
14 | Fmoc-Cys(Trt)-Cys(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
15 | Fmoc-β-Ala-Cys(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
16 | Fmoc-Cys(Acm)-Cys(Acm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
17 | Fmoc-β-Ala-Cys(Acm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
18 | Fmoc-Gln(Trt)-Gln(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
19 | Fmoc-β-Ala-Gln(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
20 | Fmoc-Glu(OtBu)-Glu(OtBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
21 | Fmoc-β-Ala-Glu(OtBu)-OH.H2O | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
22 | Fmoc-β-Ala-Gly-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
23 | Fmoc-His(Trt)-His(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
24 | Fmoc-β-Ala-His(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
25 | Fmoc-Ile-Ile-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
26 | Fmoc-β-Ala-Ile-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
27 | Fmoc-Leu-Leu-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
28 | Fmoc-β-Ala-Leu-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
29 | Fmoc-D-Leu-D-Leu-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
30 | Fmoc-β-Ala-D-Leu-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
31 | Fmoc-Lys(Boc)-Lys(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
32 | Fmoc-β-Ala-Lys(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
33 | Fmoc-Lys(Alloc)-Lys(Alloc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
34 | Fmoc-β-Ala-Lys(Alloc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
35 | Fmoc-Met-Met-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
36 | Fmoc-β-Ala-Met-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
37 | Fmoc-Orn(Boc)-Orn(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
38 | Fmoc-β-Ala-Orn(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
39 | Fmoc-Phe-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
40 | Fmoc-β-Ala-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
41 | Fmoc-D-Phe-D-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
42 | Fmoc-β-Ala-D-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
43 | Fmoc-Pro-Pro-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
44 | Fmoc-β-Ala-Pro-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
45 | Fmoc-Ser(tBu)-Ser(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
46 | Fmoc-β-Ala-Ser(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
47 | Fmoc-Ser(Trt)-Ser(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
48 | Fmoc-β-Ala-Ser(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
49 | Fmoc-Thr(tBu)-Thr(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
50 | Fmoc-β-Ala-Thr(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
51 | Fmoc-Trp(Boc)-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
52 | Fmoc-β-Ala-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
53 | Fmoc-D-Trp(Boc)-D-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
54 | Fmoc-β-Ala-D-Trp(Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
55 | Fmoc-Tyr(tBu)-Tyr(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
56 | Fmoc-β-Ala-Tyr(tBu)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
57 | Fmoc-D-Tyr(Et)-D-Tyr(Et)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
58 | Fmoc-β-Ala-D-Tyr(Et)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
59 | Fmoc-Tyr(Me)-Tyr(Me)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
60 | Fmoc-β-Ala-Tyr(Me)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
61 | Fmoc-Val-Val-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
62 | Fmoc-β-Ala-Val-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
63 | Fmoc-D-Cit-D-Cit-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
64 | Fmoc-β-Ala-D-Cit-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
65 | Fmoc-β-Ala-Dab-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
66 | Fmoc-(3-(2-naphthyl)-D-Ala)2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
67 | Fmoc-β-Ala-3-(2-naphthyl)-D-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
68 | Fmoc-(3-(3-pyridinyl)-D-Ala)2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
69 | Fmoc-β-Ala-3-(3-pyridinyl)-D-Ala-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
70 | Fmoc-(4-chloro-D-Phe)2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
71 | Fmoc-β-Ala-4-chloro-D-Phe-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
72 | Fmoc-(D-4Aph(tBuCbm))2-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
73 | Fmoc-β-Ala-D-4Aph(tBuCbm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
74 | Fmoc-Aph(L-Hor)-Aph(L-Hor)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
75 | Fmoc-β-Ala-Aph(L-Hor)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
76 | Fmoc-Lys(iPr,Boc)-Lys(iPr,Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
77 | Fmoc-β-Ala-Lys(iPr၊Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
78 | Fmoc-β-Ala-AEEA-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
79 | Fmoc-Aib-Aib-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
80 | Fmoc-β-Ala-Aib-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
81 | Fmoc-Arg-OH | ၉၁၀၀၀-၆၉-၀ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
82 | H-Arg(pbf)-OH | ၂၀၀၁၁၅-၈၆-၂ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
83 | Fmoc-D-Arg-OH | ၁၃၀၇၅၂-၃၂-၈ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
84 | HD-Arg(pbf)-OH | ၂၀၀၁၁၆-၈၁-၀ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
85 | Fmoc-HomoArg-OH.HCl | ၂၀၈၁၇၄-၁၄-၅ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
86 | H-HomoArg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
87 | Fmoc-D-HomoArg-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
88 | HD-HomoArg(pbf)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
89 | Fmoc-Asn-OH | ၇၁၉၈၉-၁၆-၇ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
90 | H-Asn(Trt)-OH | ၁၃၂၃၈၈-၅၈-၀ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
91 | Fmoc-Asp-OH | 119062-05-4 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
92 | H-Asp(OtBu)-OH | ၃၀၅၇-၇၄-၇ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
93 | Fmoc-Cys-OH | ၁၃၅၂၄၈-၈၉-၄ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
94 | H-Cys(Trt)-OH | ၂၇၉၉/၇/၇ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
95 | H-Cys(Acm)-OH.HCl | ၂၈၇၉၈-၂၈-၉ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
96 | Fmoc-Gln-OH | ၇၁၉၈၉-၂၀-၃ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
97 | H-Gln(Trt)-OH | ၁၀၂၇၄၇-၈၄-၂ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
98 | Fmoc-Glu-OH | ၁၂၁၃၄၃-၈၂-၆ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
99 | H-Glu(OtBu)-OH.H2O | ၂၄၁၉-၅၆-၉ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၀၀ | Fmoc-His-OH | ၁၁၆၆၁၁-၆၄-၄ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၀၁ | H-His(Trt)-OH | ၃၅၁၄၆-၃၂-၈ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၀၂ | Boc-His-OH | ၁၇၇၉၁-၅၂-၅ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၀၃ | Fmoc-Lys-OH | ၁၀၅၀၄၇-၄၅-၈ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၀၄ | H-Lys(Boc)-OH | ၂၄၁၈-၉၅-၃ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၀၅ | H-Lys(Alloc)-OH | ၆၂၉၈/၃/၉ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၀၆ | Fmoc-Orn-OH.HCl | 201046-57-3 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၀၇ | H-Orn(Boc)-OH | ၁၃၆၅၀-၄၉-၂ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၀၈ | Fmoc-Ser-OH | ၇၃၇၂၄-၄၅-၅ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၀၉ | H-Ser(tBu)-OH | ၁၈၈၂၂-၅၈-၇ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၁၀ | H-Ser(Trt)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၁၁ | Fmoc-Thr-OH.H2O | ၇၃၇၃၁-၃၇-၀ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၁၂ | H-Thr(tBu)-OH | ၄၃၇၈-၁၃-၆ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၁၃ | Fmoc-Trp-OH | ၃၅၇၃၇-၁၅-၆ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၁၄ | H-Trp(Boc)-OH | ၁၄၆၆၄၅-၆၃-၈ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၁၅ | Fmoc-D-Trp-OH | ၈၆၁၂၃-၁၁-၇ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၁၆ | HD-Trp(Boc)-OH | 201290-11-1 | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၁၇ | Fmoc-Tyr-OH | ၉၂၉၅၄-၉၀-၀ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၁၈ | H-Tyr(tBu)-OH | ၁၈၈၂၂-၅၉-၈ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၁၉ | Fmoc-D-Tyr-OH | ၁၁၂၈၈၃-၂၉-၁ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၂၀ | HD-Tyr(Et)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၂၁ | H-Tyr(Me)-OH.HCl | ၆၇၄၂၃-၄၄-၃ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၂၂ | Fmoc-D-4Aph(Cbm)-OH | ၃၂၄၀၁၇-၂၂-၃ | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၂၃ | HD-4Aph(tBuCbm)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၂၄ | Fmoc-Lys(iPr)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
၁၂၅ | H-Lys(iPr၊Boc)-OH | NA | ≥98.0% | ≤1.0% | ≤8.0% | ≤2.0% |
လျော်ကြေးငွေ
Gentolex သည် အရည်အသွေးကောင်းမွန်သော ထုတ်ကုန်များကို ပံ့ပိုးပေးသည်၊ အကယ်၍ လုံလောက်သော သက်သေအထောက်အထားများဖြင့် သုံးစွဲသူမှ လိုအပ်သည့်အချိန်ဘောင်အတွင်း ကုန်ပစ္စည်းအရည်အသွေးကို မြှင့်တင်ပါက၊ လျော်ကြေးပေးချေမှုဆိုင်ရာ လုပ်ထုံးလုပ်နည်းများကို အစပျိုးရန် လိုအပ်သော ခွဲခြမ်းစိတ်ဖြာမှုနှင့် အကဲဖြတ်မှုကို ပေးပါမည်။
ထုတ်လုပ်မှု
ဆေးဝါးထုတ်ကုန်များ၏ စွမ်းဆောင်ရည်သည် တန်တန်းအဆင့်သို့ရောက်ရှိပြီး၊ ဓာတုဗေဒထုတ်ကုန်များ၏ စွမ်းဆောင်ရည်များသည် တန်ချိန် 100+ အဆင့်အထိရောက်ရှိကာ ကမ္ဘာတစ်ဝှမ်းရှိ သုံးစွဲသူများအား ဝန်ဆောင်မှုပေးနိုင်ရန် စွမ်းဆောင်ရည်များ ကောင်းမွန်စွာ တပ်ဆင်ထားပါသည်။
သုတေသနနှင့် ဖွံ့ဖြိုးတိုးတက်ရေး
နှစ်စဉ်နှစ်တိုင်း၊ ရည်မှန်းချက်များချမှတ်ထားသည့်အခါတွင် မတူညီသောထုတ်ကုန်အသစ်များထုတ်လုပ်ရန် R&D အဖွဲ့မှဖွဲ့စည်းထားသော အစီအစဉ်တစ်ခုရှိပြီး၊ အဖွဲ့အတွင်းရှိအဖွဲ့ဝင်တိုင်းသည် KPI တာဝန်နှင့် မက်လုံးပေါ်လစီဖြင့် ဆက်လက်လုပ်ဆောင်ရမည်ဖြစ်ပါသည်။